These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 31379831)

  • 1. Lytic Susceptibility, Structure, and Mechanical Properties of Fibrin in Systemic Lupus Erythematosus.
    Litvinov RI; Nabiullina RM; Zubairova LD; Shakurova MA; Andrianova IA; Weisel JW
    Front Immunol; 2019; 10():1626. PubMed ID: 31379831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis.
    Collet JP; Moen JL; Veklich YI; Gorkun OV; Lord ST; Montalescot G; Weisel JW
    Blood; 2005 Dec; 106(12):3824-30. PubMed ID: 16091450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired contraction of blood clots as a novel prothrombotic mechanism in systemic lupus erythematosus.
    Le Minh G; Peshkova AD; Andrianova IA; Sibgatullin TB; Maksudova AN; Weisel JW; Litvinov RI
    Clin Sci (Lond); 2018 Jan; 132(2):243-254. PubMed ID: 29295895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure, Mechanical, and Lytic Stability of Fibrin and Plasma Coagulum Generated by Staphylocoagulase From
    Farkas ÁZ; Farkas VJ; Szabó L; Wacha A; Bóta A; Csehi L; Kolev K; Thelwell C
    Front Immunol; 2019; 10():2967. PubMed ID: 31921206
    [No Abstract]   [Full Text] [Related]  

  • 5. Interpretation and Validation of Maximum Absorbance Data Obtained from Turbidimetry Analysis of Plasma Clots.
    Pieters M; Guthold M; Nunes CM; de Lange Z
    Thromb Haemost; 2020 Jan; 120(1):44-54. PubMed ID: 31752041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA and histones impair the mechanical stability and lytic susceptibility of fibrin formed by staphylocoagulase.
    Komorowicz E; Farkas VJ; Szabó L; Cherrington S; Thelwell C; Kolev K
    Front Immunol; 2023; 14():1233128. PubMed ID: 37662916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced lysis and accelerated establishment of viscoelastic properties of fibrin clots are associated with pulmonary embolism.
    Martinez MR; Cuker A; Mills AM; Crichlow A; Lightfoot RT; Chernysh IN; Nagaswami C; Weisel JW; Ischiropoulos H
    Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(5):L397-404. PubMed ID: 24414255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant fibrinogen reveals the differential roles of α- and γ-chain cross-linking and molecular heterogeneity in fibrin clot strain-stiffening.
    Piechocka IK; Kurniawan NA; Grimbergen J; Koopman J; Koenderink GH
    J Thromb Haemost; 2017 May; 15(5):938-949. PubMed ID: 28166607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen.
    Hugenholtz GC; Macrae F; Adelmeijer J; Dulfer S; Porte RJ; Lisman T; Ariëns RA
    J Thromb Haemost; 2016 May; 14(5):1054-66. PubMed ID: 26833718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid dysfunction and fibrin network structure: a mechanism for increased thrombotic risk in hyperthyroid individuals.
    Hooper JM; Stuijver DJ; Orme SM; van Zaane B; Hess K; Gerdes VE; Phoenix F; Rice P; Smith KA; Alzahrani SH; Standeven KF; Ajjan RA
    J Clin Endocrinol Metab; 2012 May; 97(5):1463-73. PubMed ID: 22378816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease.
    Neergaard-Petersen S; Hvas AM; Kristensen SD; Grove EL; Larsen SB; Phoenix F; Kurdee Z; Grant PJ; Ajjan RA
    Thromb Haemost; 2014 Dec; 112(6):1142-50. PubMed ID: 25187394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contact activation products are new potential biomarkers to evaluate the risk of thrombotic events in systemic lupus erythematosus.
    Bäck J; Lood C; Bengtsson AA; Ekdahl KN; Nilsson B
    Arthritis Res Ther; 2013; 15(6):R206. PubMed ID: 24299152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia.
    Mastalerz L; Celińska-Lӧwenhoff M; Krawiec P; Batko B; Tłustochowicz W; Undas A
    PLoS One; 2015; 10(11):e0142167. PubMed ID: 26540111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered fibrin clot structure/function in patients with antiphospholipid syndrome: association with thrombotic manifestation.
    Celińska-Lowenhoff M; Iwaniec T; Padjas A; Musiał J; Undas A
    Thromb Haemost; 2014 Aug; 112(2):287-96. PubMed ID: 24652596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood clot contraction differentially modulates internal and external fibrinolysis.
    Tutwiler V; Peshkova AD; Le Minh G; Zaitsev S; Litvinov RI; Cines DB; Weisel JW
    J Thromb Haemost; 2019 Feb; 17(2):361-370. PubMed ID: 30582674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.
    Greenhalgh KA; Strachan MW; Alzahrani S; Baxter PD; Standeven KF; Storey RF; Ariens RA; Grant PJ; Price JF; Ajjan RA
    Thromb Haemost; 2017 Jan; 117(2):295-302. PubMed ID: 27929198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased fibrin polymerization rate in patients with primary antiphospholipid syndrome and systemic lupus erythematosus.
    de Pablo P; Ramírez A; Cortina E; de la Peña A; Zamora J; Izaguirre R; Amigo MC
    Clin Appl Thromb Hemost; 2003 Jul; 9(3):221-5. PubMed ID: 14507110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Diabetes Mellitus on Fibrin Clot Structure and Mechanics in a Model of Acute Neutrophil Extracellular Traps (NETs) Formation.
    de Vries JJ; Hoppenbrouwers T; Martinez-Torres C; Majied R; Özcan B; van Hoek M; Leebeek FWG; Rijken DC; Koenderink GH; de Maat MPM
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent venous thromboembolism patients form clots with lower elastic modulus than those formed by patients with non-recurrent disease.
    Baker SR; Zabczyk M; Macrae FL; Duval C; Undas A; Ariëns RAS
    J Thromb Haemost; 2019 Apr; 17(4):618-626. PubMed ID: 30725502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia.
    Sauls DL; Wolberg AS; Hoffman M
    J Thromb Haemost; 2003 Feb; 1(2):300-6. PubMed ID: 12871504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.